Keyphrases
Hepatocellular Carcinoma
100%
Sorafenib
100%
Oxidative Phosphorylation (OXPHOS)
100%
Sorafenib Resistance
100%
Pyruvate Dehydrogenase Kinase Inhibitor
100%
Bioenergetics
50%
Huh7
50%
Dichloroacetate
50%
Hepatocellular Carcinoma Cells
37%
Small Interfering RNA (siRNA)
25%
In Vivo Efficacy
25%
Reactive Oxygen Species
25%
Hexokinase
25%
Adenosine Triphosphate
25%
Sorafenib-resistant Hepatocellular Carcinoma
25%
Sorafenib Sensitivity
25%
Cell Viability
12%
Cancer Cells
12%
Mitochondrial Membrane Potential
12%
Tumor Regression
12%
Predictive Biomarker
12%
Induced Apoptosis
12%
Tumor Size
12%
Mouse Tumor
12%
Glycolysis
12%
Glucose Uptake
12%
Oligomycin
12%
Lactate
12%
Lactate Production
12%
Naïve Cells
12%
Cancer Metabolism
12%
Xenograft Mouse Model
12%
Subcutaneous Xenograft
12%
Hep3B
12%
Anticancer Drug Resistance
12%
Medicine and Dentistry
Hepatocellular Carcinoma
100%
Sorafenib
100%
Oxidative Phosphorylation
100%
Phosphotransferase Inhibitor
100%
Pyruvate Dehydrogenase Kinase
100%
Dichloroacetic Acid
26%
Lactic Acid
13%
Reactive Oxygen Species
13%
Small Interfering RNA
13%
Hepatocellular Carcinoma Cell Line
13%
Adenosine Triphosphate
13%
Hexokinase
13%
Epileptic Absence
6%
Malignant Neoplasm
6%
Neoplasm
6%
Programmed Cell Death
6%
In Vitro
6%
Xenograft
6%
Cancer Cell
6%
Biological Marker
6%
Cell Line
6%
Drug Resistance
6%
Tumor Regression
6%
Cell Viability
6%
Anticarcinogen
6%
Carcinoma Cell
6%
Mitochondrial Membrane Potential
6%
Glucose Uptake
6%
Oligomycin
6%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Cell Carcinoma
100%
Sorafenib
100%
Phosphotransferase Inhibitor
100%
Pyruvate Dehydrogenase Kinase
100%
Dichloroacetic Acid
26%
Malignant Neoplasm
13%
Small Interfering RNA
13%
Reactive Oxygen Metabolite
13%
Adenosine Triphosphate
13%
Lactic Acid
13%
Hexokinase
13%
Epileptic Absence
6%
Neoplasm
6%
Mouse
6%
Biological Marker
6%
Mouse Model
6%
Tumor Regression
6%
Anticarcinogen
6%
Cell Viability
6%
Drug Resistance
6%
Oligomycin
6%
Biochemistry, Genetics and Molecular Biology
Oxidative Phosphorylation
100%
Sorafenib
100%
Pyruvate Dehydrogenase Kinase
100%
Bioenergy
26%
Small Interfering RNA
13%
Adenosine Triphosphate
13%
Hexokinase
13%
Cancer Cell
6%
Cell Viability
6%
Mitochondrial Membrane Potential
6%
Mouse
6%
Metabolic Pathway
6%
Drug Resistance
6%
Mouse Model
6%
Tumor Volume
6%
Anticancer
6%
Glucose Transport
6%
Immunology and Microbiology
Oxidative Phosphorylation
100%
Sorafenib
100%
Pyruvate Dehydrogenase
100%
Bioenergy
26%
Hepatocellular Carcinoma Cell Line
13%
Mouse
6%
Xenograft
6%
Cancer Cell
6%
Mouse Model
6%
Cell Line
6%
Cell Viability
6%
Tumor Volume
6%
Drug Resistance
6%
Carcinoma Cell
6%
Mitochondrial Membrane Potential
6%
Glucose Transport
6%
Veterinary Science and Veterinary Medicine
Mouse
100%
Cancer Cell
50%
Membrane Potential
50%